At Manningham Medical Centre, you can find all the data about Genopia Biomedical. We have collected data about general practitioners, medical and surgical specialists, dental, pharmacy and more. Please see the links below for the information you need.


AIDS associated myelopathy therapy - Genopia Biomedical

    https://adisinsight.springer.com/drugs/800021272
    Genopia Biomedical in Germany was developing a blood brain barrier permeable compound for the treatment of AIDS associated myelopathy, a spinal cord disorder. AIDS …

Research programme: reperfusion injury therapies

    https://adisinsight.springer.com/drugs/800021261
    GENOPIA Biomedical GmbH in Germany was developing therapies for reperfusion injuries utilising an inhibitor of Protein-Target-Complex. GENOPIA held a number of Research …

Genopia Biomedical | Evaluate

    https://www.evaluate.com/vantage/pharmaceutical-companies/genopia-biomedical
    February 06, 2023 The slow death of the medtech Spac deal The remarkable thing is that these tie-ups are still occurring, so atrocious is their track record. February 03, 2023 …

Genopia Biomedical GmbH, Saarbrücken, Germany

    https://www.northdata.com/Genopia+Biomedical+GmbH,+Saarbr%C3%BCcken/HRB+12300
    Genopia Biomedical GmbH, Saarbrücken, Germany, District Court of Saarbrücken HRB 12300: Financial information North Data HomePremium ServicesData ServicesLogin …

Development of neuroprotective leadstructures derived …

    https://cordis.europa.eu/project/id/HPMI-CT-2002-00196
    Genopia Biomedical GmbH is a European biotechnology company focused on -Drug Development and Target Discovery -Protein Interaction Screening -Rational …

Genopia Biomedical GmbH Company Profile, Financial and …

    https://digitgaps.com/report-store/genopia-biomedical-gmbh-company-profile-financial-and-strategic-swot-analysis-mergers-and-acquisitions-partnerships-and-investments-news-key-profiles-and-competitors-report/
    digitGaps report on Genopia Biomedical GmbH delivers a detailed in-depth and comprehensive insights of the company, its history, corporate strategy, its businesses …

GENOPIA BIOMEDICAL GMBH innovation strategy - GoodIP

    https://goodip.io/iq/assignee/genopia-biomedical-gmbh
    GENOPIA BIOMEDICAL GMBH has a total of 22 patent applications. Its first patent ever was published in 1999. It filed its patents most often in EPO (European Patent Office), …

AIDS Myelopathy: Proof of concept for the therapeutical concept …

    https://www.bionity.com/en/news/32689/aids-myelopathy-proof-of-concept-for-the-therapeutical-concept-is-reached.html
    GENOPIA Biomedical GmbH announced today that a descriptive analysis of the data deriving from its clinical trial Phase II with patients suffering from AIDS Myelopathy …

Development of neuroprotective leadstructures derived …

    https://cordis.europa.eu/project/id/HPMI-CT-2002-00196/es
    FP5,QYNAD,,GENOPIA BIOMEDICAL GMBH(DE) Siga las últimas noticias y los proyectos más recientes sobre la COVID-19 y la respuesta al coronavirus de la Comisión Europea.

Collaboration on the discovery and the development of new drug …

    https://www.innovations-report.com/life-sciences/report-7454/
    GENOPIA Biomedical focuses on the development of novel drug candidates and uses advanced proteomics as its main drug discovery and high-throughput screening tool, …



Need more information about Genopia Biomedical?

At Manningham Medical Centre, we collected data on more than just Genopia Biomedical. There is a lot of other useful information. Visit the related pages or our most popular pages. Also check out our Doctors page.